...
首页> 外文期刊>Neuroscience and behavioral physiology >Cannabinoids, the Endocannabinoid System, and Cognitive Functions: Enemies or Friends?
【24h】

Cannabinoids, the Endocannabinoid System, and Cognitive Functions: Enemies or Friends?

机译:大麻素、内源性大麻素系统和认知功能:敌人还是朋友?

获取原文
获取原文并翻译 | 示例

摘要

Cannabinoids are natural compounds found in the hemp (Cannabis sativa). Scientific interest in cannabinoids arose after the discovery of the major psychoactive component in hemp, Δ9-tetrahydrocannabinol. Subsequent studies detected receptors in the brain subject to the actions of this compound, along with ligands for these receptors, i.e., endogenous cannabinoids (EC), which make up, along with the enzymes synthesizing, transporting, and degrading them, the endocannabinoid system (ECS). Interest in EC has consistently increased in recent years, especially after their important role in cognitive functions was discovered. They are regulators of synaptic transmission in the brain, mediate numerous forms of plasticity, and control neuron energy metabolism. EC exert influences using a series of mechanisms and interactions with neuromediators, neurotrophic factors, and neuropeptides. The main functions of EC in the brain are retrograde synaptic signaling and neuromodulation, which maintain cellular homeostasis. Information on the influences of cannabinoid drugs on cognitive functions is very contradictory. The cause of this may be that there are still inadequate strictly scientific data from clinical and sociological studies, while in animal experiments different authors use different methods and approaches for actions on the ECS. Thus, effects can differ depending on the substances used, their doses, and routes of administration, and the tasks and experimental conditions selected for testing. There is an extensive literature on the protective effect of ECS activation in neurodegenerative diseases in humans and models of cognitive deficit in animals. This review addresses data providing evidence of the influences of cannabinoid drugs and activation of the EC system on cognitive functions in the normal brain and in neurodegenerative diseases, Alzheimer’s disease, and temporal epilepsy. The possible causes of contradictions in existing data are also discussed.
机译:大麻素是在大麻(Cannabis sativa)中发现的天然化合物。在大麻中发现主要的精神活性成分Δ9-四氢大麻酚后,对大麻素产生了科学兴趣。随后的研究检测到大脑中受该化合物作用的受体,以及这些受体的配体,即内源性大麻素(EC),它们与合成、运输和降解它们的酶一起构成内源性大麻素系统(ECS)。近年来,人们对EC的兴趣持续增加,尤其是在发现EC在认知功能中的重要作用之后。它们是大脑突触传递的调节剂,介导多种形式的可塑性,并控制神经元能量代谢。EC 通过一系列机制以及与神经介质、神经营养因子和神经肽的相互作用来施加影响。EC在大脑中的主要功能是逆行突触信号传导和神经调控,维持细胞稳态。关于大麻素药物对认知功能影响的信息非常矛盾。造成这种情况的原因可能是临床和社会学研究的严格科学数据仍然不足,而在动物实验中,不同的作者使用不同的方法和途径对ECS采取行动。因此,效果可能因所使用的物质、剂量和给药途径以及选择用于测试的任务和实验条件而异。关于ECS激活对人类神经退行性疾病的保护作用和动物认知缺陷模型,有大量文献。本综述涉及提供大麻素药物和EC系统激活对正常大脑和神经退行性疾病、阿尔茨海默病和颞部癫痫认知功能影响的证据的数据。还讨论了现有数据中矛盾的可能原因。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号